Introducing Genomics in Healthcare and AB’s Insight into the Sector
Ed Bryan, Research Analyst—Equities and Joanne M. Hackett, Previously Chief Commercial Officer at Genomics England
About this talk
The time for talking about the potential of genomic medicine is past. Genomics is not tomorrow. It’s here today. Genomics will transform patient outcomes and healthcare systems – and Genomics England is already moving to make a mainstream genomics medicine service a reality in the UK. Please join us to discover what Genomics England are doing and how AllianceBernstein is looking at Genomics and personalized healthcare as part of our investment universe and how these companies are helping the world achieve the UN Sustainable Goals.